These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2596129)

  • 21. Use of erythromycin to inhibit carbamazepine metabolism in children with partial complex seizures.
    Curatolo P; Bruni O; Cusmai R
    Brain Dev; 1988; 10(3):206. PubMed ID: 3407860
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythromycin-induced carbamazepine intoxication in two epileptic children.
    Tagawa T; Mimaki T; Ono J; Tanaka J; Suzuki Y; Itagaki T; Yabuuchi H
    Jpn J Psychiatry Neurol; 1989 Sep; 43(3):513-4. PubMed ID: 2625794
    [No Abstract]   [Full Text] [Related]  

  • 23. Serious erythromycin interactions caused by inhibition of drug metabolism in the liver.
    Wynn RL
    Gen Dent; 1996; 44(6):486-8, 490. PubMed ID: 9515389
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.
    Steketee RW; Wassilak SG; Adkins WN; Burstyn DG; Manclark CR; Berg J; Hopfensperger D; Schell WL; Davis JP
    J Infect Dis; 1988 Mar; 157(3):434-40. PubMed ID: 3257783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbamazepine drug interactions.
    Baciewicz AM
    Ther Drug Monit; 1986; 8(3):305-17. PubMed ID: 3092407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe carbamazepine intoxication after coadministration of erythromycin.
    Goulden KJ; Camfield P; Dooley JM; Fraser A; Meek DC; Renton KW; Tibbles JA
    J Pediatr; 1986 Jul; 109(1):135-8. PubMed ID: 3723233
    [No Abstract]   [Full Text] [Related]  

  • 27. Intersubject and dose-related variability after intravenous administration of erythromycin.
    Austin KL; Mather LE; Philpot CR; McDonald PJ
    Br J Clin Pharmacol; 1980 Sep; 10(3):273-9. PubMed ID: 7437245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interactions of the macrolide antibiotics.
    Ludden TM
    Clin Pharmacokinet; 1985; 10(1):63-79. PubMed ID: 3882305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin-induced cardiac toxicity.
    Orban Z; MacDonald LL; Peters MA; Guslits B
    Am J Cardiol; 1995 Apr; 75(12):859-61. PubMed ID: 7536388
    [No Abstract]   [Full Text] [Related]  

  • 30. Dental drug interactions with the greatest potential for serious adverse effects.
    Wynn RL
    Gen Dent; 1994; 42(2):116-7. PubMed ID: 8056271
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
    Wallach PM; Love SR; Fiorica JV; Hoffman MS; Flannery MT
    J Fla Med Assoc; 1992 Dec; 79(12):821-2. PubMed ID: 1474367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phlebitis with intravenous erythromycin.
    David LM
    Am J Hosp Pharm; 1987 Apr; 44(4):732, 738. PubMed ID: 3578303
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of erythromycin on carbamazepine kinetics.
    Wong YY; Ludden TM; Bell RD
    Clin Pharmacol Ther; 1983 Apr; 33(4):460-4. PubMed ID: 6831824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate.
    Karmody CS; Weinstein L
    Ann Otol Rhinol Laryngol; 1977; 86(1 Pt 1):9-11. PubMed ID: 835977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction of erythromycin with theophylline.
    Paulsen O; Höglund P; Nilsson LG; Bengtsson HI
    Eur J Clin Pharmacol; 1987; 32(5):493-8. PubMed ID: 3622597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease inhibitor-induced carbamazepine toxicity.
    Berbel Garcia A; Latorre Ibarra A; Porta Etessam J; Martinez Salio A; Perez Martinez D; Siaz Diaz R; Toledo Heras M
    Clin Neuropharmacol; 2000; 23(4):216-8. PubMed ID: 11020127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avoiding errors with intravenous erythromycin administration.
    Donnellan F; Hussain T; McGurk C
    Eur J Intern Med; 2009 Jan; 20(1):e7-8. PubMed ID: 19237080
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythromycin: drug interactions.
    Gurevitz SL
    J Dent Hyg; 1997; 71(4):159-61. PubMed ID: 9470569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Jet intravenous injection of erythromycin lactobionate. A possible cause of the occurrence of crisis in torsade de pointe].
    Camilleri JF; Deharo JC; Panagidès D; Broin P; Mésana T; Blin D; Mouly-Bandini A; Dubouloz C; Goudard A; Montiès JR
    Ann Cardiol Angeiol (Paris); 1989 Dec; 38(10):657-9. PubMed ID: 2698118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin.
    Pasic J; Jackson SH; Johnston A; Peverel-Cooper CA; Turner P; Downey K; Chaput de Saintonge DM
    Xenobiotica; 1987 Apr; 17(4):493-7. PubMed ID: 3604256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.